Titan Pharmaceuticals
TTNP
#11028
Rank
โ‚ฌ5.46 M
Marketcap
4,11ย โ‚ฌ
Share price
-3.76%
Change (1 day)
19.45%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2023 (TTM): -0,54ย โ‚ฌ

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -3,91ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,69ย โ‚ฌ an increase over its 2021 EPS that were of -0,80ย โ‚ฌ.

EPS history for Titan Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,54ย โ‚ฌ-20.64%
2022-0,69ย โ‚ฌ-14.44%
2021-0,80ย โ‚ฌ-83.46%
2020-4,85ย โ‚ฌ-81.27%
2019-25,90ย โ‚ฌ-49%
2018-50,78ย โ‚ฌ-53.11%
2017-108,29ย โ‚ฌ-361.29%
201641,44ย โ‚ฌ-146.98%
2015-88,22ย โ‚ฌ279.31%
2014-23,26ย โ‚ฌ-120.57%
2013113,08ย โ‚ฌ-153.41%
2012-211,73ย โ‚ฌ-7.69%
2011-229,37ย โ‚ฌ160%
2010-88,22ย โ‚ฌ0%
2009-88,22ย โ‚ฌ
2007-361,70ย โ‚ฌ-2.38%
2006-370,52ย โ‚ฌ-39.13%
2005-608,72ย โ‚ฌ-16.87%
2004-732,22ย โ‚ฌ-22.43%
2003-943,95ย โ‚ฌ5.94%
2002-891,02ย โ‚ฌ60.32%
2001-555,78ย โ‚ฌ-12.5%
2000-635,18ย โ‚ฌ8.77%
1999-583,99ย โ‚ฌ-13.58%
1998-675,76ย โ‚ฌ-2800%
199725,03ย โ‚ฌ-101.76%
1996-1.420ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
5,96ย โ‚ฌ-252.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,68ย โ‚ฌ-219.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-4,13ย โ‚ฌ 5.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-0,18ย โ‚ฌ-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-0,20ย โ‚ฌ-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,88ย โ‚ฌ-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA